NEDD4L and nonpapillary renal cell carcinoma: Therefore, we concluded that downregulated NEDD4L in ccRCC might lead to metabolic disorder and immune deficiency, inhibit cell apoptosis, promote cell growth, migration, and adhesion, and further induce the development of ccRCC.